From the correlation analysis of MFAP4 with immune infiltration, immune checkpoint inhibitors, chemokines, and chemokine receptor expression in gliomas, it is clear that MFAP4 may play an important role in tumor immunity and that inhibition of MFAP4 is a feasible immunotherapeutic strategy for glioma. Here, MFAP4 is linked to central nervous system cancer.